Covid-19 drug Favipiravir safe, effective, says Glenmark

Favipiravir was used to treat patients with moderate to mild Covid-19.On 19 June 2020, Glenmark Pharmaceuticals received the restricted emergency use approval from the DCGI for Favipiravir (FabiFlu)